A Pilot Study Comparing the Immunogenicity of Fendrix vs. Double-dose Engerix B in HIV-infected Non-responders to Standard Hepatitis B Vaccination Courses

Clinical trial NCT02434848 · COMPLETED

Trial details

NCT number: NCT02434848
Sponsor: Sheffield Teaching Hospitals NHS Foundation Trust
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

HIV Communicable Diseases Hepatitis B HBV Infectious Diseases

Start date: 2015-07-23
Primary completion: 2022-06-10
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.